Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare

Ikonisys SA (Euronext Growth Paris: ALIKO), a leader in cancer detection through automated solutions, has launched a new website to promote Fluorescence In Situ Hybridization (FISH) technology. This technology is crucial for identifying genetic abnormalities associated with diseases, especially cancer.

According to Ikonisys, FISH technology has revolutionized molecular diagnostics by enhancing the speed, accuracy, and scalability of mass screenings. Their automated systems streamline laboratory processes, allowing for the efficient handling of increased volumes while maintaining high-quality standards.

Ikonisys' new website details the benefits of total automation, which include advanced imaging algorithms and artificial intelligence for improved data analysis and early detection. These innovations aim to facilitate personalized treatment plans, resulting in better patient outcomes. The platforms are designed to integrate seamlessly into existing laboratory workflows, reducing manual errors and boosting productivity.

Alessandro Nosei, CDO and Brand Manager at Ikonisys, emphasized the website's role as an informative hub for healthcare professionals. "We invite professionals and stakeholders to explore our platform and join us in advancing healthcare through innovation," he stated.

For more information, visit www.ikonisys.com.